Xuefeng Guo Selected Research

Xuefeng Guo Research Topics

Disease

9	Neoplasms (Cancer) 11/2023 - 12/2012
5	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 06/2013
2	Pathologic Constriction (Stenosis) 12/2023 - 10/2021
2	Thyroid Neoplasms (Thyroid Cancer) 11/2023 - 12/2012
2	Neoplasm Metastasis (Metastasis) 11/2023 - 10/2014
2	COVID-19 01/2023 - 01/2021
2	Rectal Neoplasms (Rectal Cancer) 10/2022 - 10/2021
2	Colorectal Neoplasms (Colorectal Cancer) 07/2022 - 01/2016
2	Inflammation (Inflammations) 01/2022 - 11/2014
2	Endometritis 08/2021 - 11/2020
2	Infections 06/2017 - 01/2009
2	Human Influenza (Influenza) 05/2014 - 09/2011
2	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 04/2013 - 11/2011
1	Appendicitis 12/2024
1	Papillary Thyroid Cancer 11/2023
1	Adenoma (Adenomas) 01/2023
1	Wounds and Injuries (Trauma) 11/2022
1	Neoplasm Micrometastasis 07/2022
1	Alcoholic Intoxication (Drunkenness) 01/2022
1	Ischemic Stroke 01/2022
1	Alzheimer Disease (Alzheimer's Disease) 01/2022
1	Infarction (Infarctions) 01/2022
1	Necrosis 01/2022
1	Pain (Aches) 01/2022
1	Stroke (Strokes) 01/2022
1	Proctitis 10/2021
1	Hemorrhage 09/2020
1	Fatty Liver 01/2020
1	Non-alcoholic Fatty Liver Disease 01/2020
1	Intraoperative Complications 09/2019
1	Anastomotic Leak 09/2019
1	Ileus 09/2019
1	Weight Gain 05/2019
1	Enteritis 11/2014
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2014
1	Carcinoma (Carcinomatosis) 05/2014
1	Hypoxia (Hypoxemia) 05/2014
1	Hypertriglyceridemia 08/2013
1	Abdominal Obesity 08/2013
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2013

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 11/2023 - 05/2014
5	Messenger RNA (mRNA)IBA 11/2023 - 05/2014
3	RNA (Ribonucleic Acid)IBA 11/2023 - 01/2009
2	ChemokinesIBA 08/2022 - 04/2020
2	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2022
2	HMGB1 Protein (HMG1)IBA 08/2021 - 11/2020
2	Immunoglobulin G (IgG)IBA 01/2021 - 01/2009
2	Small Interfering RNA (siRNA)IBA 10/2014 - 05/2014
2	SiliconIBA 05/2014 - 09/2011
1	Long Noncoding RNAIBA 04/2024
1	Fibronectins (Fibronectin)IBA 11/2023
1	Capsules (Microcapsules)IBA 11/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	PolymersIBA 11/2022
1	Coloring Agents (Dyes)IBA 10/2022
1	LigandsIBA 08/2022
1	Interleukin-17 (Interleukin 17)IBA 01/2022
1	Autophagy-Related ProteinsIBA 01/2022
1	Beclin-1IBA 01/2022
1	AcidsIBA 01/2022
1	AldehydesIBA 01/2022
1	EstersIBA 01/2022
1	Free RadicalsIBA 01/2022
1	IronIBA 01/2022
1	TubulinIBA 01/2022
1	IntegrinsIBA 01/2022
1	SynaptophysinIBA 01/2022
1	Vesicular Glutamate Transport Protein 1IBA 01/2022
1	OsteopontinIBA 01/2022
1	EndotoxinsIBA 08/2021
1	Immunoglobulin M (IgM)IBA 01/2021
1	VaccinesIBA 01/2021
1	AntibodiesIBA 01/2021
1	LipopolysaccharidesIBA 11/2020
1	gamma-Butyrobetaine DioxygenaseIBA 01/2020
1	Triglycerides (Triacylglycerol)IBA 01/2020
1	N,N,N-trimethyl-5-aminovaleric acidIBA 01/2020
1	Nonesterified Fatty Acids (NEFA)IBA 01/2020
1	Carnitine (L-Carnitine)FDA LinkGeneric 01/2020
1	Immunoglobulins (Immunoglobulin)IBA 05/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2017
1	3' Untranslated Regions (3' UTR)IBA 01/2016
1	CollagenIBA 10/2014
1	CateninsIBA 10/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2014
1	OsteocalcinIBA 08/2013
1	CholesterolIBA 08/2013

Therapy/Procedure

2	Therapeutics 12/2024 - 09/2020
2	Neoadjuvant Therapy 10/2022 - 07/2022
2	Semiconductors 04/2013 - 11/2011
1	Colonoscopes 12/2023
1	Nutritional Support (Artificial Feeding) 01/2023
1	Immunotherapy 08/2022
1	Drug Therapy (Chemotherapy) 07/2022
1	Stents 07/2022
1	Intravenous Injections 01/2022
1	Conscious Sedation 01/2022
1	Ileostomy 10/2021
1	Endoscopic Hemostasis 09/2020
1	Operative Time 09/2019